Read Full Story Levi Strauss & Co. has recognized the Harvard Chan SHINE program (Sustainability and Health Initiative for Netpositive Enterprise) for its role in advancing the health and well-being of the people who make Levi Strauss clothing around the world.The program, founded and led by Eileen McNeely, Instructor in the Department of Environmental Health, has been conducting worker well-being research in Levi Strauss supplier factories around the globe. By working with SHINE, Levi Strauss has been able to identify areas for improvement in working conditions. More than 13,000 apparel workers, mostly women, working in factories across Cambodia, China, Mexico, Poland, and Sri Lanka, have been positively impacted by this research.Through this multi-year study, SHINE’s research has found that by actively cultivating trust, respect and fairness, supplier factories have improved gender equality, well-being and productivity. Levi Strauss aims to leverage these findings to continue strengthening factory policies and systems — and to continue worker empowerment programs — in order to continue improving the well-being of the workers the company relies on to manufacture its products.
Lowell Bailey of Lake Placid, New York became the first ever American, male or female, to win gold at the International Biathlon Union World Championship. The biathlon is the only winter sport the U.S. had failed to win gold for in the Olympics or World Championships until now. Bailey finished the 20-kilometer race in 48 minutes 7.4 seconds just 3.3 seconds faster than second place and 21 seconds faster than the 11-time world champion Martin Fourcade. The New Yorker hit all 20 targets only three other competitors managed the same.At 35, Bailey is one of the oldest athletes competing at the top level. Although this win was the highlight of his championships, he also finished fourth in the sprint, and sixth the pursuit. The three-time Olympian, soon to be four time, trains at the Maine Winter Sports Center in Fort Kent, Maine.
Russia on Thursday rolled out a drug approved to treat patients suffering from the novel coronavirus, its state financial backer said, as the number of infections there surpassed half a million.The first deliveries of the new antiviral drug, registered under the name Avifavir, were made to some hospitals and clinics across the country, Russia’s RDIF sovereign wealth fund said in a press release. RDIF has a 50% share in a joint venture with the drug’s manufacturer ChemRar that runs the trials.The health ministry gave its approval for the drug’s use under a special accelerated process while clinical trials, held over a shorter period and with fewer people than many other countries, were still underway. Topics : With 502,436 cases, Russia has the third highest number of infections in the world after Brazil and the United States, but has a relatively low official death toll of 6,532 – something that has been the focus of debate.The Moscow health department on Wednesday raised its death toll for the month of May, citing changes in the way it determines the cause of death for patients suffering from other health problems.Kremlin spokesman Dmitry Peskov on Thursday denied there was anything untoward with Russia’s official coronavirus death data after the World Health Organization said this week that Russia’s low death rate was “difficult to understand”. There is currently no vaccine for COVID-19, the disease caused by the new coronavirus, and human trials of several existing antiviral drugs have yet to show efficacy.RDIF chief Kirill Dmitriev last week told Reuters the plan was for ChemRar to manufacture enough of the drug to treat around 60,000 people a month.Dmitriev on Thursday said more than 10 countries had made requests for Avifavir supplies.Negotiations were underway to supply the drug to almost all of Russia’s regions, with seven of its more than 80 regions receiving Thursday’s initial deliveries, Dmitriev added.
Macke remains second in the MVC in digs in conference matches this season and is the lone underclassman ranked in the top five. Macke led the Bulldogs with 38 digs in a pair of MVC road wins last week to average 5.43 digs per set in the team’s 3-1 win at Evansville and 3-0 sweep at Indiana State. The wins extended the Bulldogs’ win streak to 10 matches, the fifth-longest active win streak in the nation. She and the rest of her teammates will face one of their biggest challenges of the season Friday, Oct. 13, when they welcome fellow MVC leader Missouri State to the Knapp Center. Both teams enter Friday’s 7 p.m. match with perfect 6-0 records on the MVC. Print Friendly Version ST. LOUIS, Mo. – Drake University freshman libero Kylee Macke (Ankeny, Iowa) has been named the Missouri Valley Conference Volleyball Defensive Player of the Week, the league announced Monday, October 9. Macke helped hold Drake’s opponents to just 0.098 hitting in the wins to keep Drake on top of the MVC standings at 6-0. The freshman opened the weekend with a team-high 26 digs at Evansville, the second-highest total of her career and highest in a four-set match. She added 12 digs in the three-set win at Indiana State.